Publications

Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis

 94
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis

Tags:

Previous Article

A new type of immune defense in E. coli

Next Article

Predicting progression of multiple sclerosis

Related Posts

Glycine-modulating Slc6a20a-ASO restores NMDA receptor function in SHANK2 and SHANK3-mutant mice and cortical organoids

Glycine-modulating Slc6a20a-ASO restores NMDA receptor ...

 87

Multi-omics profiling of cachexia-targeted tissues reveals a spatio-temporally coordinated response to cancer

Multi-omics profiling of cachexia-targeted tissues reve...

 57

White matter lesions disrupt cholinergic pathways important for cognition in Parkinson’s disease

White matter lesions disrupt cholinergic pathways impor...

 50